Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
33.41
+3.31 (11.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Structure Therapeutics Employees
Structure Therapeutics had 93 employees as of December 31, 2023. The number of employees increased by 25 or 36.76% compared to the previous year.
Employees
93
Change (1Y)
25
Growth (1Y)
36.76%
Revenue / Employee
n/a
Profits / Employee
-$1,188,710
Market Cap
1.91B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Dec 31, 2022 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 18,000 |
| Patterson Companies | 7,600 |
| Teladoc Health | 5,600 |
| Integra LifeSciences Holdings | 3,946 |
| AtriCure | 1,200 |
| Arvinas | 445 |
| RxSight | 374 |
| Tarsus Pharmaceuticals | 244 |
GPCR News
- 8 days ago - Structure Therapeutics to Participate in the Jefferies London Healthcare Conference - GlobeNewsWire
- 10 days ago - Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity - GlobeNewsWire
- 4 weeks ago - Structure Therapeutics: Potential To Have Best-In-Class GLP-1 Agonist For Obesity Patients - Seeking Alpha
- 2 months ago - Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. - GlobeNewsWire
- 3 months ago - Structure Therapeutics Appoints Angus C. Russell to Board of Directors - GlobeNewsWire
- 3 months ago - Structure Therapeutics Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Obesity drugs' next wave: These companies could snag 20% of GLP-1 market, analysts say - Market Watch
- 3 months ago - Structure Therapeutics: Pay Attention To This Overlooked Player In GLP-1 Weight Loss Field - Seeking Alpha